FDA
-
-
-
-
-
-
-
Ambrx Appoints Audit Executive Chris Nolet to Board of Directors
-
-
-
-
-
-
-
Viela Bio (VIE) Confirms U.S. FDA Approval of UPLIZNA for Treatment of Neuromyelitis Optica Spectrum Disorder
-
-
-
-
-
-
-
Viela Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
-
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

